These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8910924)

  • 21. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro tumour cell growth inhibition: a comparative study between allosensitized cytotoxic T lymphocytes and lymphokine activated killer cells.
    Fuggetta MP; Alvino E; Pepponi R; De Filippi R; Marini S; Bonmassar E
    Cell Prolif; 1993 Jul; 26(4):305-16. PubMed ID: 8343559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.
    Baltuch GH; Villemure JG; McCrea E; Antel JP
    Neurosurgery; 1994 Sep; 35(3):450-6; discussion 456. PubMed ID: 7800136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation.
    Geldhof AB; Van Ginderachter JA; Liu Y; Noël W; Raes G; De Baetselier P
    Blood; 2002 Dec; 100(12):4049-58. PubMed ID: 12393627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity.
    Fuggetta MP; Lanzilli G; Cottarelli A; Ravagnan G; Cartenì M; De Maria S; Metafora BM; Metafora V; Metafora S
    J Reprod Immunol; 2008 Jul; 78(2):85-93. PubMed ID: 18243331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells.
    Peck R; Brockhaus M; Frey JR
    Cell Immunol; 1989 Aug; 122(1):1-10. PubMed ID: 2502315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood].
    Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R
    Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R; Coleman N; Stanley M
    Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
    Nissen-Meyer J; Espevik T
    Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumor necrosis factor-alpha gene.
    Tashiro T; Yoshida J; Mizuno M; Sugita K
    J Neurosurg; 1993 Feb; 78(2):252-6. PubMed ID: 8421207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced susceptibility of electroporated tumor cell lines to killing by cytotoxic lymphocytes.
    Dressel R; Baraki H; Langer F; Günther E
    Biochem Biophys Res Commun; 1998 Sep; 250(2):259-63. PubMed ID: 9753617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
    Bean P; Agah R; Mazumder A
    J Biol Response Mod; 1990 Feb; 9(1):92-7. PubMed ID: 2181073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells.
    Baral E; Nagy E; Krepart GV; Lotocki RJ; Unruh HW; Berczi I
    Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.
    Koberda J; Przepiorka D; Moser RP; Grimm EE
    Lymphokine Cytokine Res; 1994 Apr; 13(2):139-45. PubMed ID: 8061115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
    Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity.
    Baxevanis CN; Voutsas IF; Soler MH; Gritzapis AD; Tsitsilonis OE; Stoeva S; Voelter W; Arsenis P; Papamichail M
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):355-72. PubMed ID: 9736441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.